The grants were awarded through the organization's Diagnostic Accelerator, a partnership between the charity and various philanthropic partners.
In PNAS this week: tRNA fragment signature for chronic lymphocytic leukemia, genomic sites sensitive to ultraviolet radiation in melanocytes, and more.
The company is hoping its technology can help predict which melanoma patients will respond to checkpoint inhibition using immune-related gene expression signals.
The search uncovered two post-traumatic stress disorder loci in Europeans and a third in individuals with African ancestry, highlighting immune- and brain-related genes.
The analysis further found that the degree of network perturbation correlated with the severity of toddlers' autism spectrum disorder.
The San Diego-based firm has developed a new extracellular RNA sequencing method that it believes could be used for cancer diagnostics.
Researchers warn that there are finite ancient samples for genetic analysis and argue that policies should be in place to ensure they are studied responsibly.
In PNAS this week: transcriptomic and epigenomic sequence differences in glioblastoma models, approach to analyze small amounts of extracellular RNA, and more.
MIT's Technology Review reports that researchers hope to develop a CRISPR-based pain therapy.
Two BioRxiv preprints describe new algorithms that the developers say can accelerate the pace of genome analysis.
Nature News reports that gene therapy approaches are tackling sickle cell disease, but that the cost of treatment is a concern.
The Washington Post reports that a US Senate committee voted this week to approve the nomination of Stephen Hahn to lead the Food and Drug Administration.
One gene regulates hundreds of others to influence facial development, according to New Scientist.
In Nature this week: resources for single-cell analysis, little overlap in the microRNAs used by Salmonella and Shigella to infect host cells, and more.